Legacy Law Firm, LLC

Legacy Law Firm, LLC Philip J. Corson, Attorney
PO Box 100
Bowling Green, SC 29703
(mailing address)
All locations by appointment only
planningyourlegacy.com

Whether he’s teaching his daughter how to climb a tree (Philip now requires a much a sturdier tree than he did as a kid), or designing and developing a customized estate plan to protect what’s most important to you, he simply enjoys helping others do more of what they want, when they want, with the people they care about. Philip is licensed to practice law in both North Carolina and South Carolina

. We have worked with thousands of families in the areas of Estate Planning, Living Trusts, Wills (simple & complex), Powers of Attorney, Living Wills, Irrevocable Trusts, Family Limited Partnerships, Charitable Gifting Strategies, Probate, Trust Administration, LGBT, Incapacity, Retirement Planning, Elder Law, Medicaid, Asset Protection, Special Needs and Financial Planning. Ayrsley Location 2015 Ayrsley Town Blvd Ste 202 Charlotte NC 28273

Ballantyne Location 3440 Toringdon Way Ste 205 Charlotte NC 28277

Rock Hill Location 331 E Main St Ste 200 Rock Hill SC 29730

It Cost Them Everything: Remembering the Fallen on Memorial DayThe death toll of the Civil War was so high, it's difficu...
05/24/2026

It Cost Them Everything: Remembering the Fallen on Memorial Day

The death toll of the Civil War was so high, it's difficult for us to imagine today. More than 2% of the U.S. population perished in just four years of conflict.1

By comparison to today's population, that would be like losing nearly 7 million soldiers. And that doesn't include those who were maimed or suffered deep psychological damage. It was a bitter war that left no family untouched.

Immediately after the Civil War ended, people, particularly women, would go and lay flowers on the graves of the dead. One of the most notable of these occasions was in 1865 when a large procession was held in Charleston, SC, to commemorate the lives of Union soldiers who had died in a makeshift prisoner of war camp at the local racecourse. Thousands of black Americans, many of whom had been enslaved months earlier, decorated the mass grave with baskets of flowers, wreaths, and crosses.2

In 1868 these spontaneous, local events led to the creation of a national day of commemoration to be observed each year on May 30. It was called "Decoration Day."

According to the New York Times, as the day evolved to honor all troops who had fallen while serving their country, Americans began referring to the observance as "Memorial Day." An NYT article from May 31, 1870 noted that, aside from Independence Day, there was "no day that calls out the patriotic feelings of our people more than 'Memorial Day.'"

But it wasn't until almost a hundred years later that Congress finally renamed the day Memorial Day. A few years after that it was moved from May 30 to the last Monday of the month to make a long weekend and give people the opportunity to gather.

If you sometimes get the purpose of Memorial Day mixed up with that of Veterans Day (November 11), you're not alone. Many people think that both days are for honoring those who served in the military. But if you just think back to the origins of Memorial Day, laying flowers on graves, it's easier to remember that it's specifically to remember those who have fallen in war.

This Memorial Day we hope you have the chance to get together with family and friends and maybe fire up the barbecue. As you enjoy this unofficial "first day of summer," take a moment to pause and remember those who gave their last full measure of devotion while serving our country.

03/13/2026

Could a Dementia Vaccine be on the Horizon?

ENCOURAGING RESULTS FROM ONE TRIAL

AC Immune, a Swiss pharmaceutical company, has developed ACI-24, a vaccine that appears to “train” immune systems to clear amyloid plaque before it accumulates into Alzheimer's pathology. In prevention trials of 312 individuals with genetic Alzheimer's risk, 89% remained cognitively normal past expected onset ages, with brain imaging showing minimal protein accumulation. According to the company, the vaccine works like traditional vaccines – exposing the immune system to modified forms of toxic proteins so antibodies form. These antibodies circulate constantly, binding to amyloid-beta and tau proteins when they misfold, marking them for immune “clearance” before aggregation in the brain occurs. Trial participants received initial vaccination series (3 doses over 6 months) and then annual boosters. Individuals whose parents or siblings developed Alzheimer's in their 60s remained dementia-free into their 70s, a psychological relief for families who are concerned about genetic predisposition. The vaccine costs approximately $12,000 for initial series plus $2,500 annual boosters – far less than Alzheimer's care costs ($350,000+ lifetime per patient). Insurance coverage depends on FDA approval, which is anticipated in 2026-2027. Over 7 million Americans currently suffer from Alzheimer's, but 100+ million carry genetic risks for the disease.

02/11/2026

Advancements in Alzheimer’s Research

RECENT BREAKTHROUGHS SHOW PROMISE

Alzheimer’s disease is the most common form of dementia. It affects 10 percent of adults over age 65 and kills more people each year than breast cancer and prostate cancer combined, according to the Alzheimer’s Association. Scientists have studied the disease extensively for decades, but clinical trials and new drug tests consistently yielded disappointing results. In recent months, however, there have been substantive advancements in the identification and treatment of the disorder. While none of these breakthroughs are a cure, there is evidence that some new solutions may delay the progression of the disease, which gives families time for planning and treatment-making decisions. Progress has been made in the way of brain imaging and gene editing. Another exciting development is a new blood biomarker that can detect the beginnings of tau pathology, which senses the build-up of amyloid protein in the brain, a hallmark of Alzheimer’s. And the FDA has approved new drugs that have been shown to delay the memory loss that occurs with an Alzheimer’s diagnosis. Kisunia and Lequembi are two such drugs. New advancements in blood testing and epidemiology are also driving progress toward more effective treatment solutions.

01/10/2026

What Scientists Now Know About Aging

THE EYES HAVE IT

A new study published in Science Advances on October 24, 2025 found that retinal scans may be a new way for medical professionals to detect issues with heart health. To conduct this research, investigators analyzed retinal scans, as well as genetics and blood biomarkers. They discovered molecular pathways that help explain how aging affects the vascular system, according to Marie Pigeyre, senior author of the study and a professor with McMaster's Department of Medicine. She noted that potential biological causes behind changes in the eye's blood vessels helped them identify “specific proteins that may drive aging and disease.” This suggests that scans of the retina may soon prove to be a non-invasive method for earlier detection of vascular issues and health problems and lead to more comprehensive preventive care.

12/23/2025

Address

PO Box 100 (mailing Address)
Bowling Green, SC
29703

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm

Telephone

+18037467000

Website

Alerts

Be the first to know and let us send you an email when Legacy Law Firm, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category